Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease
Barrett J. Rollins
Barrett J. Rollins
Published November 1, 2001
Citation Information: J Clin Invest. 2001;108(9):1269-1271. https://doi.org/10.1172/JCI14273.
View: Text | PDF
Commentary

Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease

  • Text
  • PDF
Abstract

Authors

Barrett J. Rollins

×

Total citations by year

Year: 2018 2015 2010 2009 2007 2005 2004 Total
Citations: 1 1 1 1 1 1 1 7
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (7)

Title and authors Publication Year
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
P Ruytinx, P Proost, JV Damme, S Struyf
Frontiers in immunology 2018
Foam cells and the pathogenesis of kidney disease:
M Eom, KL Hudkins, CE Alpers
Current Opinion in Nephrology and Hypertension 2015
The role of endothelial interleukin-8/NADPH oxidase 1 axis in sepsis
T Miyoshi, K Yamashita, T Arai, K Yamamoto, K Mizugishi, T Uchiyama
Immunology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale
S Man, EE Ubogu, RM Ransohoff
Brain Pathology 2007
Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation
RJ Phillips, M Lutz, B Premack
Journal of inflammation (London, England) 2005
Analysis of leukocyte extravasation across the blood-brain barrier: Conceptual and technical aspects
MK Callahan, RM Ransohoff
Current Allergy and Asthma Reports 2004

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts